Note 1: Values are rounded up or down to the nearest digit.
Note 2: The year ended December 2015 are based on the nine-month period (April-December) for the Company and subsidiaries with March 31 fiscal year-ends, and the 12-month period (January-December) for subsidiaries with December 31 fiscal year-ends, due to a change in fiscal year period.
|Highlights for the Year Ended December 2017
- Net sales for the fiscal year under review increased 16.0% year on year on a local currency basis. This resulted from such factors as global growth in the prestige market segment where the company has increased strategic investment, and the cumulative effect of new brands added by the Group since last fiscal year. When converted into yen, net sales reached ¥1,005.1 billion, an increase of 18.2% year on year, due to the positive effect of yen depreciation.
- Operating income rose 118.7% year on year to \80.4 billion. This was mainly due to an increase in the operating margin accompanying the growth in sales, improved efficiency in marketing investment and benefits derived from cost structure reform.
- Net income attributable to owners of parent was ¥22.7 billion, a decrease of 29.1% year on year. This decrease resulted from the expense of voluntary recalls of some products and the recognition of an impairment loss on intangible and other assets related to Bare Escentuals, Inc. in the Americas as an extraordinary loss. This loss exceeded the extraordinary income recognized for the gain on the sale of Zotos shares and related assets.
- For the fiscal year under review, the consolidated operating margin was 8.0%. Consolidated return on equity was 5.6%.
Operating Income / Operating Profitability
Net Income Attributable to Owners of Parent/ Net Earnings per Share
Net Assets / ROE
Interest-bearing Debt / Interest-bearing Debt Ratio